Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon

林可瀚 醫師



 中文姓名 林可瀚    



 Lin, Ko-Han



  1. 正子電腦斷層(PET/CT)影像
  2. 釔90微球體治療
  3. 硼中子捕獲治療




  1. 臺北榮民總醫院核醫部住院醫師
  2. 臺北榮民總醫院核醫部住院總醫師
  3. 臺北榮民總醫院桃園分院家醫科主治醫師









  1. Lin KH, Lee RC, Liu, RS, Chang CY. The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism. Nucl Med Commun.  2016 Apr;37(4):356-62
  2. Lin KH, Chang CP, Liu RS, Wang SJ. F-18 FDG PET/CT in evaluation of pulmonary sclerosing hemangioma. Clin Nucl Med. 2011 May;36(5):341-3.
  3. Chang CY, Yang BH, Lin KH, Liu RS, Wang SJ, Shih WJ. Feasibility and incremental benefit of puffed-cheek 18F-FDG PET/CT on oral cancer patients. Clin Nucl Med. 2013 Oct;38(10):e374-8.
  4. Lin WY, Hsu WH, Lin KH, Wang SJ. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer. J Chin Med Assoc. 2012 May;75(5):203-8.
  5. Bhatia K, Mok G, Lin K, Choi F. A diffuse branching pattern of biliary FDG activity: infective or neoplastic? Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):165-6
  6. Chang CY, Lin KH, Chu YK, Chang CP, Liu RS, Wang SJ. Incidental finding of autosomal dominant polycystic kidney disease with liver involvement on Tc-99m sestamibi scintigraphy. Clin Nucl Med. 2011 Jul;36(7):e69-70.
  7. Liu CS, Lin KH, Lee RC, Tseng HS, Wang LW, Huang PI, Chao LS, Chang CY, Yen SH, Tung CJ, Wang SJ, Wong CY, Liu RS, Model-based Radiation Dose Correction for Yttrium-90 Microsphere Treatment of Liver Tumors with Central Necrosis. Internation Journal of Radiation Oncology, Biology, Physics. 2011;81(3):660-8.
  8. Chiu CH, Yeh YC, Lin KH, Wu YC, Lee YC, Chou TY, Tsai CM. Histological subtypes of lung adenocarcinoma have differential 18F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. J Thorac Oncol. 2011 Oct;6(10):1697-703.
  9. Hsu PK, Lin KH, Wang SJ, Huang CS, Wu YC, Hsu WH. Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients. World J Surg. 2011 Jun;35(6):1321-6.
  10. Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS, Hsieh CC, Wu YC. Positron Emission Tomography-Computed Tomography in Predicting Locoregional Invasion in Esophageal Squamous Cell Carcinoma. The Annals of thoracic surgery. 2009 May;87(5):1564-8.
  11. Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ. The feasibility of C-11-methionine-PET in diagnosis of solitary lung nodules/masses when compared with F-18-FDG-PET. Annals of Nuclear Medicine. 2008 Jul;22(6):533-8.



1.       Lin KH, Lee RC, Liu CS et al. “The Tc-99m MAA Imaging Predicts the Response of Yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Thrombosis”, 11th Congress of the World Federation of Nuclear Medicine and Biology, August 27~31, 2014, Cancun, Mexico.

2.       Lin KH, Wang SJ, Wang LW et al. “Reduction of Tumor Uptake on Interim 18F-FBPA-PET Predicts the Therapeutic Response of Boron Neutron Capture Therapy”, 16th International Congress on Neutron Capture Therapy, June 14~19, 2014, Helsinki, Finland.

3.       Lin KH, Lee RC, Liu CS et al. “The Value of Whole-body FDG-PET/CT in Detection of Extrahepatic Metastases in Hepatocellular Carcinoma Patients Treated with Yttrium-90 Radioembolization”, Annual Congress of the European Association of Nuclear Medicine, October 27~31, 2012, Milan, Italy.Lin KH, Liu RS, Wang SJ et al. “Pros And Cons Of Evaluation Of Mediastinal Lymph Nodes Metastases Of Esophageal Cancer By PET/CT In The Endemic Area Of Granulomatous Disease”, 2012 Society of Nuclear Medicine Annual Meeting, June 9~13, 2012, Miami, U.S.A.

4.       Lin KH, Liu RS, et al. “The Value Of Tumor Shadow Disappearance Rate On Integrated PET/CT In Evaluation Of Solitary Pulmonary Nodules With Low Glucose Metabolism”, 2011 Society of Nuclear Medicine Annual Meeting, June 4~8, 2011, San Antonio, U.S.A.

5.       Lin KH, Lee RC et al. “Evaluating Response to Yttrium-90 Radioembolization in Hepatocellular Carcinoma with FDG-PET/CT: Based on PERCIST Criteria”, Annual Congress of the European Association of Nuclear Medicine, Oct. 9~13 2010, Vienna, Austria.

6.       Lin KH, Lee RC et al. “Impact Of Early PET Response In Predicting The Outcome Of Liver Malignancies After Yttrium-90 Radioembolization”, Imaging 2010, June 8~11 2010, Stockholm, Sweden.

7.       Lin KH, Liu RS et al. “Evaluating Yttrium-90 Microsphere Treatment Response Of Liver Metastases: PERCIST Versus RECIST”, 13th Asian Oceanina Congress of Radiology, March 20~23 2010, Taipei, TAIWAN

8.       Lin KH, Liu RS et al. “Evaluation of Response to Yttrium-90 SIRT in Hepatocellular Carcinoma with Dual-Tracer PET/CT Imaging: Initial Experience”, 2009 Radiologic Society of North America Annual Meeting, Nov 29~Dec 4 2009, Chicago, U.S.A.